BridgeMD
Tests treatment safety and results for Psoriasis
Official title Managing Psychological Distress Through Mindfulness-based CBT to Evaluate Its Effectiveness on Self-compassion Among Psoriasis Patients:The Mediating Role of Mental Health Locus of Control
ClinicalTrials.gov ID: NCT07615257
What this study is testing
- What it's testing
- Your research study is about evaluating the effectiveness of \ \ Mindfulness-Based Cognitive Therapy (MBCT)\ \ in reducing psychological distress among psoriasis patients and improving their self-compassion and Mental Health Locus of Control (MHLC). The study highlights that psoriasis patients often suffer not only from physical symptoms but also from psychological problems such as stress, anxiety, depression, self-judgment, and low self-compassion.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 75
You may be able to join if
- Diagnosed psoriasis patients
- Age between 18 and 65 years
- Both male and female participants
- Participants willing to provide informed consent
- Participants experiencing psychological distress
You likely can't join if
- Under the age of 18 years will be excluded.
- Patients with severe psychiatric disorders
- Patients currently receiving other psychological therapies
- Patients with serious medical or neurological conditions
- Participants unwilling to continue the intervention sessions
- Patients with cognitive impairment affecting participation
The study team makes the final eligibility decision.
Where it's taking place
- Rahim Yar Khan, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 25 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rahim Yar Khan, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.